Education
About Us
Working with TipRanks
Follow Us
Revelation Biosciences (REVB)
NASDAQ:REVB
Revelation Biosciences (REVB) Ownership Overview
40.92% Insiders
0.02% Mutual Funds
6.15% Other Institutional Investors
52.91% Public Companies and
Individual Investors
The ownership structure of Revelation Biosciences (REVB) stock is a mix of institutional, retail, and individual investors. , 40.92% is owned by Insiders, and 52.91% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,334,149 | Insider | 22.52% | 1,266,107 | |
| 869,435 | Insider | 14.68% | 825,094 | |
| 73,357 | Insider | 1.24% | 69,616 | |
| 73,353 | Insider | 1.24% | 69,612 | |
| 73,353 | Insider | 1.24% | 69,612 | |
| 1,136 | Institution | 0.02% | 1,078 | |
| 355 | Insider | <0.01% | 337 | |
| 12 | Institution | <0.01% | 37 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,136 | Institution | 0.02% | 1,078 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Revelation Biosciences (REVB)?
According to the latest TipRanks data, approximately 6.15% of the company's stock is held by institutional investors, 40.92% is held by insiders, and 52.91% is held by retail investors.
What percentage of Revelation Biosciences (REVB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.15% of Revelation Biosciences (REVB) stock is held by institutional investors.
What percentage of Revelation Biosciences (REVB) stock is held by retail investors?
According to the latest TipRanks data, approximately 52.91% of Revelation Biosciences (REVB) stock is held by retail investors.
Who owns the most shares of Revelation Biosciences (REVB)?
James Rolke owns the most shares of Revelation Biosciences (REVB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.